Skip to content

ATW-001

Multicenter study of lens posterior chamber lenses in patients with moderate to degree myopia or myopia astigmatism-efficacy and safety verification test on ATW001-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2032210430
Enrollment
104
Registered
2021-11-19
Start date
2022-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia,myopia astigmatism

Interventions

ATW-001 is customized according to the subject's eye condition and inserted through the corneal incision into the posterior chamber(back of the iris).

Sponsors

Ishibashi Taro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cases in which written consent was obtained from the patient himself / herself Cases in which prescribed postoperative examinations may be possible during the study period Cases where he/she can understand the contents of the consent explanation document and sign the consent form

Exclusion criteria

Exclusion criteria: Cases of active external ocular inflammation Cases with cataract nuclear myopia Not limited to nuclear cataracts, but also includes cases with abnormalities such as opacity or subluxation of the crystalline lens. Cases with active endoocular inflammation associated with uveitis or scleritis Cases with high intraocular pressure Cases with systemic or immunodeficiency disorders that are likely to affect wound care, such as severe diabetes and severe atopic dermatitis Cases which are pregnant or breastfeeding Cases with superficial anterior chamber and corneal endothelial cell damage Cases of glaucoma whose treatment cannot be controlled by drugs, etc. Cases with systemic connective tissue disease Cases with suspected or history of macular degeneration or macular edem Cases with amblyopia or blindness in one eye Cases with progressive lesions that affect vision excludes retinal lesions associated with myopia Cases with ocular surface disease Cases judged by the investigator to be inappropriate as subjects

Design outcomes

Primary

MeasureTime frame
far-sighted naked-eye visual acuity 1 year after surgery

Contacts

Public ContactTaro Ishibashi

Atworking K.K.

t.ishibashi@atworking.com+81-3-5577-5595

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026